Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital

Kontaktoplysninger

Thomas Huneck Haupt
Klinisk Forskningscenter
Hvidovre Hospital
Kettegård Allé 30
2650 Hvidovre
E-mail: thomas.h.haupt@gmail.com
Født d. 23. august 1985.

Uddannelse

2009-2013, Københavns Universitet, cand. med.
"Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study” (karakter: 12)
 

2006-2009, Københavns Universitet, bach. med.
”Latente HIV-reservoirs og immunstimulation” (karakter: 12)
  
2002-2005, Borupgaard Amtsgymnasium, matematisk student
Karaktergennemsnit: 10,8 på 13-skala


Ansættelser

2010-2011, Klinisk Forskningscenter, prægraduat forskningsårsstuderende
Jeg nåede i den periode at designe, få godkendt og gennemført et klinisk studie på AMA, Hvidovre Hospital, som nu er publiceret i Critical Care. 
  
2011-, Klinisk Forskningscenter, forskningsassistent
Jeg arbejder for tiden (sommeren 2013) på at forberede mit ph.d.-projekt om Crohns sygdom og immunologi. Arbejder desuden videre med suPAR på rent epidemiologisk plan (Inter99-studiet).
  
2011-2013, Køge Sygehus, Medicinsk Afdeling, medicinsk mellemvagt


Publikationer

Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality

Törnkvist, P. B. S., Haupt, T. H., Rasmussen, L. J. H., Ladelund, S., Toft, U., Pisinger, C. & Eugen-Olsen, J., mar. 2019, I: The British journal of nutrition. 121, 6, s. 699-708 10 s.

Healthy lifestyles reduce suPAR and mortality in a Danish general population study

Haupt, T. H., Rasmussen, L. J. H., Kallemose, T., Ladelund, S., Andersen, O., Pisinger, C. & Eugen-Olsen, J., 22 jan. 2019, I: Immunity and Ageing. 16, 1, 1.

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study

Rasmussen, L. J. H., Ladelund, S., Haupt, T. H., Ellekilde, G. E., Eugen-Olsen, J. & Andersen, O., dec. 2018, I: Critical Care Medicine. 46, 12, s. 1961-1968

One-Stop Dispensing: Hospital Costs and Patient Perspectives on Self-Management of Medication

Houlind, M. B., McNulty, H. B. Ø., Treldal, C., Andersen, S. L., Huneck Haupt, T., Petersen, J., Andersen, O. & Kjeldsen, L. J., maj 2018, I: Pharmacy (Basel, Switzerland). 6, 2

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients

Meyer, J., Alstrup, M., Rasmussen, L. J. H., Schultz, M., Ladelund, S., Haupt, T. H., Tingleff, J., Iversen, K. & Eugen-Olsen, J., 1 feb. 2018, I: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 26, 11

How inflammation underlies physical and organ function in acutely admitted older medical patients

Klausen, H. H., Bodilsen, A. C., Petersen, J., Bandholm, T., Haupt, T., Sivertsen, D. M. & Andersen, O., jun. 2017, I: Mechanisms of Ageing and Development. 164, s. 67-75

A high-protein diet during hospitalization is associated with an accelerated decrease in soluble urokinase plasminogen activator receptor levels in acutely ill elderly medical patients with SIRS

Tavenier, J., Haupt, T. H., Andersen, A. L., Buhl, S. F., Langkilde, A., Andersen, J. R., Jensen, J-E. B., Pedersen, M. M., Petersen, J. & Andersen, O., maj 2017, I: Nutrition Research. 41, s. 56-64

Prognostic value and pathophysiological role of suPAR in low- and high-risk populations

Haupt, T. H., Nordgaard-Lassen, I., Andersen, O., Petersen, J. & Eugen-Olsen, J., 2017

Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study

Lindboe, J. B., Langkilde, A., Eugen-Olsen, J., Hansen, B. R., Haupt, T. H., Petersen, J. & Andersen, O., dec. 2016, I: Infectious diseases (London, England). 48, 11-12, s. 829-837

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study

Rasmussen, L. J. H., Ladelund, S., Haupt, T. H., Ellekilde, G., Poulsen, J. H., Iversen, K., Eugen-Olsen, J. & Andersen, O., nov. 2016, I: Emergency medicine journal : EMJ. 33, 11, s. 769-775

Letters to the Editor: Genetic polymorphism and soluble urokinase plasminogen activator receptor regulation

Rasmussen, L. J. H., Haupt, T. H., Andersen, O. & Eugen-Olsen, J., dec. 2015, I: F A S E B Journal. 29, 12, s. 4757-8 2 s.

Immunosenescence of the CD8(+) T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls

Tavenier, J., Langkilde, A., Haupt, T. H., Henriksen, J. H., Jensen, F. K., Petersen, J. & Andersen, O., nov. 2015, I: B M C Immunology. 16, 72, s. 1-14

Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population

Haupt, T. H., Kallemose, T., Ladelund, S., Jee Hartmann Rasmussen, L., Thorball, C. W., Andersen, O., Pisinger, C. & Eugen-Olsen, J., 2014, I: Biomarker Insights. 9, s. 91-100 10 s.

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study

Haupt, T. H., Petersen, J., Ellekilde, G., Klausen, H. H., Thorball, C. W., Eugen-Olsen, J. & Andersen, O., 2012, I: Critical Care (Online Edition). 16, 4, s. R130

ID: 38400597